FDA Grant Establishes Complex Generics Center To Increase Access
Key Component Of The FDA’s Drug Competition Action Plan
Complex active ingredients, formulations, routes of delivery, and drug-device combination products are to receive greater attention as part of attempts to facilitate competition after the US FDA awarded a $5m grant to establish a dedicated research center.
